HCPCS Level IIdrugActive
J1575
Hyqvia 100mg immuneglobulin
BETOS: O1E
Effective: 2016-01-01
Referenced in 5 policies
Description
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hyqvia
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
100 MG
Billing Units
25.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.